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The antimicrobial agents triclosan (TCS;
2,4,4´-trichloro-2´-hydroxydiphenyl ether)
and triclocarban (TCC; 3,4,4´-trichloro-
carbanilide) are high-production-volume
chemicals that are widely used as “value
added” chemicals in personal care products. In
a limited retail survey, approximately 45% of
liquid and bar soaps on the market contained
these antimicrobials; TCS and TCC were the
predominant antimicrobials in liquid soaps
and bar soaps, respectively (Perencevich et al.
2001). According to the U.S. Environmental
Protection Agency (2007), U.S. consumers
spend nearly $1 billion/year on these products.
TCS is a broad-spectrum bacteriostatic germi-
cide that is now used in consumer products
such as liquid hand soap, toothpaste, mouth
rinse, cosmetics, pharmaceutical products, fab-
rics, plastics, textiles, and plastic kitchenware
since its original introduction as an active
ingredient in a surgical scrub for professional
health care in 1972 (Tierno 1999). It is a pow-
erful antibacterial agent that inhibits the activ-
ity of the enzyme enoyl-acyl carrier-protein
reductase, which catalyzes an essential step in
membranes of many bacteria and fungi (Heath
et al. 1999; McMurry et al. 1998b). TCC,
another antimicrobial agent, is more often
added to consumer bar soaps and deodorants,
and it is active predominantly against gram-
positive bacteria (McDonnell and Russell
1999). The carbanilide analog 3-trifluo-
romethyl-4,4´-dichlorocarbanilide (TFC) is
also used as an antibacterial agent (Jeffcoat
et al. 1977).
Although these compounds are broadly
classified as halogenated aromatic hydro-
carbons, TCS has functional moieties represen-
tative of phenols, diphenyl ethers, and
polychlorinated biphenyls (PCBs), whereas
TCC is structurally related to carbanilide com-
pounds, including some drugs and pesticides,
and sterically and electronically related to a
variety of other chemicals (Figure 1). Both
TCS and TCC have been detected at micro-
gram per liter levels in waterways in the United
States and Switzerland, indicating extensive
contamination of aquatic ecosystems (Halden
and Paull 2005; Kolpin et al. 2002; Lindstrom
et al. 2002). The potential of these compounds
for bioaccumulation has raised public concern
regarding their possible effects on human
health (Coogan et al. 2007; Darbre 2006;
Daughton and Ternes 1999) and microbial
resistance (McMurry et al. 1998a). Recent
reports note that TCS levels as high as
2,000 μg/kg lipid have been detected in human
breast milk (Dayan 2007), and concentrations
in human fluids such as plasma and milk are
positively correlated to levels of exposure
(Adolfsson-Erici et al. 2002; Allmyr et al. 2006;
Dayan 2007; Hovander et al. 2002).
Because of these concerns, we screened
TCS, TCC, and a series of TCC analogs for
biological activity in several mechanistically
derived cell-based assay systems. Mammalian
ligand-dependent nuclear receptors serve as
biomarkers that evaluate the potential of an
environmental toxicant to affect endocrine
and non–endocrine-signaling systems. One
set of assays used in the present study is based
on the chemically activated luciferase gene
expression (CALUX) bioassays. The recombi-
nant cells used in the CALUX bioassays
include a stably transfected aryl hydrocarbon
receptor (AhR)-, androgen receptor (AR)-, or
estrogen receptor (ER)-responsive firefly
luciferase reporter gene that responds to
chemicals that can bind to and/or activate the
respective receptor, leading to the induction
of luciferase reporter gene expression.
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Ki Chang Ahn,1 Bin Zhao,2 Jiangang Chen,3 Gennady Cherednichenko,4 Enio Sanmarti,5 Michael S. Denison,2
Bill Lasley,3 Isaac N. Pessah,4 Dietmar Kültz,5 Daniel P.Y. Chang,6 Shirley J. Gee,1 and Bruce D. Hammock1
1Department of Entomology and Cancer Research Center, 2Department of Environmental Toxicology, 3Center for Health and
Environment, 4Department of Molecular Biosciences and Center for Children’s Environmental Health and Disease Prevention,
5Department of Animal Science, and 6Department of Civil and Environmental Engineering, University of California, Davis, Davis,
California, USA
BACKGROUND: Concerns have been raised about the biological and toxicologic effects of the anti-
microbials triclocarban (TCC) and triclosan (TCS) in personal care products. Few studies have
evaluated their biological activities in mammalian cells to assess their potential for adverse effects.
OBJECTIVES: In this study, we assessed the activity of TCC, its analogs, and TCS in in vitro
nuclear-receptor–responsive and calcium signaling bioassays.
MATERIALS AND METHODS: We determined the biological activities of the compounds in in vitro,
cell-based, and nuclear-receptor–responsive bioassays for receptors for aryl hydrocarbon (AhR),
estrogen (ER), androgen (AR), and ryanodine (RyR1).
RESULTS: Some carbanilide compounds, including TCC (1–10 µM), enhanced estradiol (E2)-
dependent or testosterone-dependent activation of ER- and AR-responsive gene expression up to
2.5-fold but exhibited little or no agonistic activity alone. Some carbanilides and TCS exhibited
weak agonistic and/or antagonistic activity in the AhR-responsive bioassay. TCS exhibited antago-
nistic activity in both ER- and AR-responsive bioassays. TCS (0.1–10 µM) significantly enhanced
the binding of [3H]ryanodine to RyR1 and caused elevation of resting cytosolic [Ca2+] in primary
skeletal myotubes, but carbanilides had no effect.
CONCLUSIONS: Carbanilides, including TCC, enhanced hormone-dependent induction of ER- and
AR-dependent gene expression but had little agonist activity, suggesting a new mechanism of action of
endocrine-disrupting compounds. TCS, structurally similar to noncoplanar ortho-substituted poly-
chlorinated biphenyls, exhibited weak AhR activity but interacted with RyR1 and stimulated Ca2+
mobilization. These observations have potential implications for human and animal health. Further
investigations are needed into the biological and toxicologic effects of TCC, its analogs, and TCS. 
KEY WORDS: androgen receptor, antimicrobial, aryl hydrocarbon receptor, bioactivity, carbanilide
analog, estrogen receptor, ryanodine receptor, sensitization, signal amplification, triclocarban, tri-
closan. Environ Health Perspect 116:1203–1210 (2008). doi:10.1289/ehp.11200 available via
http://dx.doi.org/ [Online 16 May 2008]
AhR is a transcription factor that activates
gene expression in a ligand-dependent man-
ner. Exposure to the most potent ligand,
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),
results in a variety of toxic and biological
responses, most of which are AhR dependent,
such as birth defects, immunotoxicity, tumor
production, changes in metabolism, and
lethality. Dioxin-like PCBs, polychlorinated
dibenzofurans, and related chemicals that
mimic the action of TCDD at the level of the
AhR are detected by measurement of their
ability to stimulate AhR-dependent gene
expression in the CALUX bioassay (Garrison
et al. 1996; Han et al. 2004).
Steroid hormones control reproduction,
metabolism, and ion balance in vertebrates.
ER and AR are nuclear receptors for estro-
genic and androgenic chemicals such as estra-
diol (E2) and testosterone, respectively, that
function as transcription factors to regulate
female and male reproduction, sexual develop-
ment, and bone structure. Chemicals acting as
endocrine-disrupting compounds (EDCs)
affect these receptors and lead to activation/
inhibition of hormone-dependent gene expres-
sion. However, EDCs may also alter hormone
receptor function simply by changing phos-
phorylation of the receptors (activating them)
without the responsible chemical or natural
ligand ever binding to the receptor (Weigel
and Moore 2007). Recently, Chen et al.
(2008) reported data indicating a mechanism
of endocrine disruption that involves the
receptor but that does not appear to act
through competition with the receptor’s pri-
mary binding site. Instead, they observed an
amplification or enhancement of the ability of
the chemical to stimulate gene expression in
concert with the natural ligand, possibly indi-
cating a new type of EDC that may not share
the basic qualities of previously defined EDCs.
An increasing number of studies report
that chemicals in the environment, mimicking
natural estrogen, interact with or affect the ER
in cells and thereby disrupt normal endocrine
function, raising public concerns about the
biological/reproductive effects of these chemi-
cals (Darbre 2006). Reproductive health con-
cerns regarding androgenic EDCs that may
reduce sperm production, alter genital develop-
ment, and contribute to neurologic syndromes
in males have been proposed (Chen et al.
2007; Larsson et al. 2006; Sonneveld et al.
2005). In relation to the work reported here,
TCS may have cytotoxic effects on breast can-
cer cells (Liu et al. 2002) and have endocrine-
disrupting properties (antiandrogenic activity
and thyroid-hormone-like activity) in aquatic
species and human recombinant cells in cul-
ture (Chen et al. 2007; Foran et al. 2000;
Veldhoen et al. 2006).
The ryanodine (Ry) receptor type 1
(RyR1)-based bioassay is used for screening
potential compounds exhibiting biological
activity that alters Ca2+ homeostasis (Pessah
et al. 2006). RyRs function as high-conductance
Ca2+ channels broadly expressed in animal cells,
including muscle (skeletal, cardiac, smooth),
neurons, and immune cells. Chemicals that
enhance or inhibit RyR channel activity, such
as caffeine and Ry, have been demonstrated to
influence Ca2+ signaling events and Ca2+-
dependent processes in a number of cell types.
Noncoplanar, ortho-substituted PCB congeners
that exhibit weak AhR activity enhance the
sensitivity of RyRs to activation by endogenous
ligands in a manner requiring the immuno-
philin FKBP12–RyR complex (Wong et al.
1997). Disruption of Ca2+ homeostasis in the
affected regions of the brain by compounds
altering RyR may contribute to alteration of
neurodevelopment and neuroplasticity func-
tion (Gafni et al. 2004; Wong et al. 2001).
The screening assays used in this study are
part of a library of techniques developed by
the University of California, Davis Superfund
Basic Research Program, whose aim is to
identify biomarkers of exposure and effect of
toxic substances. The goal of this study was to
demonstrate that such mechanistic, nuclear-
receptor–based screening assays can rapidly
provide useful information on environmental
chemicals, and to assess the potential for the
antimicrobials TCC, its analogs, and TCS
to produce specific toxic effects that would
warrant further study.
Materials and Methods
Chemicals. Compounds, identified by Roman
numerals in the text, are listed in Figure 1;
compounds were either purchased or synthe-
sized in this laboratory. The carbanilide com-
pounds, carbanilide (I; reported purity,
99.9%), TCC (III; reported purity, 99.3%),
and 1,3-dicyclohexylurea (VI; reported purity,
> 98%) were purchased from Aldrich (St.
Louis, MO); 3-trifluoromethyl-4,4´-dichloro-
carbanilide (VII; reported purity, > 99%) was
purchased from Chembridge (San Diego, CA).
We synthesized structurally related carbanilide
compounds (II, IV, and V; purity, > 99%) by
condensing the appropriate isocyanate and
amine according to previously published
reports (Morisseau et al. 1999; Newman et al.
2001). We purchased TCS (VIII; reported
purity of 99.8%) from Fluka (St. Louis, MO).
The commercial TCC (III) and TCS (VIII)
compounds were further purified to approxi-
mately 100% purity by recrystallization three
times from ethanol and petroleum ether,
respectively. We obtained TCDD from S. Safe
(Texas A&M University, College Station, TX).
We purchased dimethyl sulfoxide (DMSO),
17β-E2, and phenol red-free Dulbecco’s modi-
fied Eagle medium (DMEM) from Sigma
Chemical Co. (St. Louis, MO); cell culture
reagents and media from Gibco/BRL (Grand
Island, NY); and 17β-testosterone from Alltech
(State College, PA). All test compounds, except
for the steroids, were dissolved in DMSO;
steroids were dissolved in absolute ethanol. We
Ahn et al.
1204 VOLUME 116 | NUMBER 9 | September 2008 • Environmental Health Perspectives
Figure 1. Chemical structures and use of TCC, its analogs, and TCS.
Compound Common name Chemical structure Remark (production)
I Carbanilide Possible by-product in
the synthesis of the
herbicide siduron
II 4,4’-Dichlorocarbanilide Possible by-product in
the synthesis of
triclocarban and the
insecticide diflubenzuron
III 3,4,4’-Trichlorocarbanilide, Antimicrobial agent
triclocarban (TCC)
IV 3,3’,4,4’-Tetrachloro- Possible by-product in
carbanilide the synthesis of
triclocarban and the
herbicide diuron
V 4’-Methoxy-3,4-dichloro- Structurally related
carbanilide carbanilide compound
VI 1,3-Dicyclohexylurea By-product in the
synthesis of peptide
VII 3-Trifluoromethyl-4,4’-dichloro- Antimicrobial agent
carbanilide (TFC)
VIII 2,4,4’-Trichloro-2’-hydroxydiphenyl Antimicrobial agent
ether, triclosan (TCS)
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purchased [3H]Ry (60–90 Ci/mmol; > 99%
pure) from Perkin-Elmer New England
Nuclear (Wilmington, DE) and unlabeled
Ry (> 99% by ultraviolet-HPLC from
Calbiochem (San Diego, CA).
Cell-based AhR-mediated bioassay.
Recombinant rat hepatoma (H4L1.1c4) cells
were grown and maintained as previously
described (Garrison et al. 1996). These cells
contain the stably integrated, dioxin-
responsive–element (DRE)-driven firefly
luciferase reporter gene plasmid pGudLuc1.1.
Transcriptional activation of the plasmid
occurs in a ligand-, dose-, and AhR-dependent
manner. Cells were plated into white, clear-
bottomed 96-well tissue culture dishes at
75,000 cells/well and allowed to attach for
24 hr. Cells were incubated with carrier solvent
DMSO (1% final solvent concentration),
TCDD (1 nM), the indicated compound (for
measurement of agonist activity), or the indi-
cated compound plus 1 nM TCDD (for meas-
urement of antagonist activity) for 4 hr at
37°C. For luciferase measurement, sample
wells were washed twice with phosphate-
buffered saline, followed by addition of cell
lysis buffer (Promega, Madison, WI); the
plates were then shaken for 20 min at room
temperature to allow cell lysis. We measured
luciferase activity in each well using a Lucy2
microplate luminometer (Anthos, Durham,
NC) with automatic injection of Promega sta-
bilized luciferase reagent. Luciferase activity in
each well was expressed relative to that maxi-
mally induced by TCDD.
Cell-based ER-mediated bioassay.
Recombinant human ovarian cancer cells
(BG1Luc4E2, ER-α–positive) were grown and
maintained as previously described (Rogers
and Denison 2000). These cells contain a sta-
bly integrated, ER-responsive firefly luciferase
reporter plasmid, pGudLuc7ERE. Cells were
maintained in estrogen-stripped media for
5 days before they were plated into white,
clear-bottomed 96-well tissue culture dishes at
75,000 cells/well and allowed to attach for
24 hr. Cells were then incubated with carrier
solvent (ethanol; 1% final solvent concentra-
tion), E2 (1 nM), the indicated compound
(for measurement of agonist activity), or the
indicated compound plus 1 nM E2 (for meas-
urement of antagonist activity) for 24 hr at
37°C. We measured luciferase activity as
described above; activity is expressed relative
to that maximally induced by E2.
Cell-based AR-mediated bioassays. For the
cell-based human AR-responsive bioassay,
recombinant human cells [T47D-androgen-
responsive element (ARE)] were grown and
maintained as described above for H4L1.1c4
cells. The T47D-ARE cells contain a stably
integrated AR-responsive firefly luciferase
reporter gene plasmid, pGudLuc7ARE
(Rogers and Denison 2002). Cells were plated
into white, clear-bottomed 96-well tissue cul-
ture dishes at 75,000 cells/well and allowed to
attach for 24 hr. Cells were incubated with
carrier solvent (ethanol; 1% final solvent con-
centration), 10 μM testosterone, the indicated
compound (for measurement of agonist activ-
ity), or the indicated compound plus the indi-
cated concentration of testosterone (for
measurement of antagonist activity) for 24 hr
at 37°C. We measured luciferase activity as
described above; activity in each well is
expressed relative to that maximally induced
by testosterone. For comparison, we present
data from a previously published study on the
effect of these chemicals on AR in human
embryonic kidney (HEK) 2933Y cells that
lack key steroid-metabolizing enzymes (Chen
et al. 2008). 
RyR1-mediated bioassay. Preparation of
primary cultures of skeletal myotubes from
wild-type mice has been previously described
(Rando and Blau 1994). Wild-type myoblasts
were cultured in treated dishes coated with calf
skin collagen with F-10 nutrient medium con-
taining 20% (vol/vol) fetal bovine serum,
2 mM L-glutamine, 4 ng/mL fibroblast
growth factor, 100 units/mL penicillin-G, and
100 μg/mL streptomycin sulfate at 37°C in
10% CO2/5% O2. For fura-2 imaging, cells
were plated onto 96-well μ-clear plates
(Greiner Bio-One GmbH, Monroe, NC)
coated with Matrigel (Becton Dickinson,
Franklin Lakes, NJ). Upon reaching ~ 80%
confluency, the cells were differentiated into
multinucleated myotubes over a period of
3 days using DMEM containing 5% (vol/vol)
heat-inactivated horse serum, 2 mM L-gluta-
mine, penicillin-G, and streptomycin sulfate
at 37°C in 10% CO2/10% O2. Intracellular
Ca2+ signals were recorded as previously
described (Fessenden et al. 2000). Briefly, dif-
ferentiated primary wild-type myotubes were
loaded with the calcium indicator dye fura-2,
and the cells were imaged using an intensified
charge-coupled device camera. 
The [3H]Ry-binding assay was performed
as previously described (Pessah et al. 1987).
Observation of [3H]Ry binding to the iso-
lated sarcoplasmic reticulum preparation was
performed in the presence of 1 nM [3H]Ry
and 10 μM Ca2+. The binding reaction was
carried out at 37°C for 3 hr in 0.5 mL con-
taining 50 μg sarcoplasmic reticulum protein.
We assessed nonspecific binding in the pres-
ence of 10 μM unlabeled Ry. We separated
bound and free ligand by rapid filtration
through Whatman GF/B glass fiber filters,
using a Brandel (Gaithersburg, MD) cell har-
vester. Filters were washed with 2 volumes of
5 mL ice-cold wash buffer containing 20 mM
Tris-HCl, 250 mM KCl, 15 mM NaCl, and
50 μM CaCl2 (pH 7.1) and placed in vials
with 5 mL scintillation cocktail (Ready Safe,
Beckman Instruments, Fullerton, CA). We
quantified [3H]Ry remaining on the filters by
liquid scintillation spectrometry.
Data analysis. We measured luciferase
activity per well as relative light units. We cal-
culated luciferase induction as a percentage of
TCDD (AhR bioassay), E2 (ER bioassay), or
testosterone (AR bioassay) activity by setting
the maximal induction by 1 nM TCDD,
1 nM E2, or 10 μM testosterone at 100%.
Background activity present in the vehicle con-
trol was subtracted from treated cells. For
antagonistic effects in the AhR bioassay, the
induction at 1 nM concentration of TCDD
was set at 100%. When evaluating for enhance-
ment effects of the hormone receptors in the
CALUX bioassays, the induction at a concen-
tration of 1 nM E2 (ER bioassay) or 10 μM
testosterone (AR bioassay) was set at 100%, and
the degree of enhancement by each compound
tested was calculated as the ratio of the
luciferase reporter gene induction value of each
compound when combined with E2 or testos-
terone relative to that of the hormone alone. 
We calculated the fold increase of [3H]Ry
binding by TCS in skeletal muscle sarcoplas-
mic reticulum vesicles by dividing the mean
value of [3H]Ry binding triggered by TCS
with that triggered by the solvent control
(DMSO); the solvent had none of the effects
seen with TCS. Values shown are mean ± SD
from three independent experiments for each
dose tested, with vehicle control values sub-
tracted. We analyzed data by one-way analysis
of variance, followed by a multiple compari-
sons test when appropriate, using SigmaStat
version 3.5 (Systat Software, San Jose, CA).
We set the level of significance at p < 0.05.
Molecular modeling of TCS. We performed
molecular modeling using the CS ChemOffice
2005 software package (CambridgeSoft Corp.,
Cambridge, MA). We compared the optimized
geometries of 2,2´,3,5´,6-pentachlorobiphenyl
(PCB-95) and TCS at their minimum energy
levels with a minimum root mean square gra-
dient of 0.1 computed by MM2 force fields.
We measured the dihedral angles formed by
two phenyl rings in the structures of PCB-95
and TCS after molecular modeling; three-
dimensional projections of the structures of
TCS and PCB-95 were simulated using
ChemIDplus (National Library of Medicine
2008). 
Results
Cell-based AhR-mediated bioassay. We evalu-
ated the activity of AhR-mediated cells by
measuring luciferase activity induced by test
compounds compared with that of the solvent
control (DMSO) or TCDD as positive con-
trol. As shown in Table 1, no carbanilide com-
pounds tested (I–VII) exhibited induction
except 1,3-dicyclohexylurea (VI), which
induced reporter gene activity to 51% of that
induced by TCDD. Interestingly, induction
Bioactivities of triclocarban, its analogs, and triclosan
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by compound VI was lower at the higher con-
centration, suggesting that it may be toxic to
the cells, although we observed no overt cell
toxicity by visual inspection. Except for com-
pound VI, all carbanilides at higher concentra-
tions (10 μM) inhibited TCDD-dependent
luciferase gene expression between 20% and
70%, suggesting that these chemicals may act
as weak AhR antagonists.
We tested TCS (compound VIII) in the
AhR bioassay because of its structural similarity
to hydroxylated metabolites of the polybromi-
nated diphenyl ethers 2,4,4´-tribromodiphenyl
ether [bromodiphenyl ether-28 (BDE-28)], and
2,2´,4,4´-tetrabromodiphenyl ether (BDE-47).
TCS, at 10 μM, not only induced luciferase
expression to 40% of that of TCDD induction
but also inhibited the induction of luciferase
expression by TCDD by approximately 30%.
These agonist/antagonist results are consistent
with TCS being a partial agonist of the AhR.
Cell-based ER- or AR-mediated bioassay.
We evaluated activity of the recombinant ER-
or AR-responsive cells by measuring luciferase
activity induced by E2 or testosterone, respec-
tively, and compared results from the car-
banilide compounds with solvent controls
or positive controls (E2, testosterone).
Coincubation of E2 and TCC resulted in
enhanced E2-dependent induction of luciferase
gene expression, with significant increases
observed at 1–10 nM E2 (Figure 2A). We also
examined the effect of TCC on the ability of
testosterone to induce AR-mediated reporter
gene activity; similar to results with the ER-
reporter system, TCC enhanced testosterone-
dependent induction of luciferase gene
expression in T47D-ARE cells, but only at the
highest concentration (10 μM) of testosterone
(Figure 2B). Amplification of testosterone-
dependent induction of ARE-linked luciferase
reporter gene in a stably transfected HEK
293-ARE cell line has been previously pub-
lished (Chen et al. 2008), although that study
reported the enhancement effect to occur at
testosterone concentrations as low as 0.1 nM.
Together, these results demonstrate that TCC
can exert an enhancing effect on at least two
members of the steroid hormone receptor fam-
ily of transcription factors. Whether other
related receptors will be similarly affected
remains to be determined.
The activity of TCC in the ER- and AR-
responsive cells provides an interesting mecha-
nism to enhance the endocrine-disrupting
activity of chemicals. To determine whether
other carbanilides also exert similar hormone-
enhancing activity and whether they have any
estrogenic or androgenic activity, we examined
the ability of these chemicals to induce ER- or
AR-dependent luciferase reporter gene activity
and to enhance/inhibit hormone (E2/T)-
dependent reporter gene induction in the cell
bioassays. As shown in Figure 3A, TCC and
its analogs, at concentrations of 1 or 10 μM,
exhibited weak ER activity, < 30% of maximal
E2-induced reporter gene induction; dicyclo-
hexylurea (VI) induced ER-dependent gene
expression only at 10 μM. Interestingly, com-
pound VI at 10 μM induced ER-dependent
reporter gene expression to a level significantly
greater than that of a maximally inducing con-
centration of E2. The results of the combined
treatment of the carbanilides and E2 (Figure 3B)
revealed an enhancement of E2-dependent
gene expression by several compounds, with
some being more effective enhancers at the
lower concentration (I, III, and V) and one
(VI) being a more effective E2 enhancer at the
higher concentration, increasing maximal E2-
dependent induction by 2.5-fold. The dra-
matic reduction in E2-dependent induction of
luciferase by compounds III, IV, and VII at
10 μM resulted from cell toxicity, as deter-
mined by visual inspection.
Examination of the ability of the carbani-
lide compounds to induce AR-dependent
reporter gene activity (Figure 3C) revealed that
most compounds either were inactive or had
very low agonist activity (inducing luciferase
activity to < 10% of a maximal inducing con-
centration of testosterone). When combined
with testosterone (10 μM), the four carbanilide
compounds (I, II, III, and V) at 1 μM enhanced
testosterone-dependent gene expression,
whereas compounds I, II, V, and VI at 10 μM
enhanced luciferase gene induction to a signifi-
cantly greater degree than observed with 1 μM
(Figure 3D). The reduction in testosterone-
dependent induction of luciferase activity by
compounds III, IV, and VII at 10 μM resulted
from cell toxicity as determined by microscopic
examination. At 1 μM, compounds IV and VII
did not enhance testosterone-dependent
reporter gene expression. As shown in
Figure 4A, all test compounds were inactive in
Ahn et al.
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Table 1. Induction or inhibition of AhR-dependent luciferase reporter gene expression in H4L1.1c4 cells.
Luciferase activity (percent of TCDD)
Compound 1 µM of compound 10 µM of compound
Induction of luciferase
TCDD 100 ± 8 100 ± 8
I 2.0 ± 0.1 1.8 ± 0.2
II 0.1 ± 1.7a 0.6 ± 0.1a
III (TCC) 0.8 ± 0.4a 1.2 ± 0.3a
IV 0.1 ± 0.2a 0.1 ± 0.5a
V 0.5 ± 0.7 1.3 ± 0.4
VI 50.9 ± 1.5* 13.6 ± 1.9
VII 8.5 ± 0.6 3.6 ± 0.2*
VIII (TCS) 6.0 ± 1.5 40.6 ± 6.1*
Inhibition of TCDD induction of luciferase
DMSO 100 ± 8 100 ± 8
I 85.9 ± 4.4* 80.3 ± 0.6a*
II 61.4 ± 0.7a* 81.3 ± 4.4a*
III (TCC) 64.6 ± 3.2a* 50.7 ± 2.8a*
IV 75.1 ± 2.5a* 33.4 ± 4.1a*
V 98.2 ± 3.2 79.3 ± 4.6*
VI 103 ± 2 112 ± 3
VII 97.1 ± 2.0 32.5 ± 1.6*
VIII (TCS) 98.3 ± 5.5 70.4 ± 2.1*
Values are expressed as a percentage of that induced by 1 nM TCDD and represent the mean ± SD of triplicate determi-
nations of luciferase activity. 
aData from Zhao et al. (2006). *Significantly different from the DMSO-treated controls or TCDD-treated samples (p < 0.05). 
Figure 2. Results of ER- and AR-mediated bioassays showing the effects of 1 µM TCC on gene expression of
ER (A) and AR (B) induced by E2 in BG1-ERE cells and testosterone (T) in T47D-ARE cells, respectively.
Luciferase activity (mean ± SD) is expressed relative to that maximally induced by E2 and T in (A) and (B),
respectively. 
*Significantly greater than E2 or T positive control groups (p < 0.05).
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HEK 2933Y-ARE cells; however, when com-
bined with testosterone at a physiologically rel-
evant concentration of 0.1 nM in HEK
2933Y-ARE cells (Figure 4B), the 1-μM con-
centration of the carbanilide compounds,
except for TFC (VII), exhibited a range of
20–100% amplification of testosterone-
induced AR activity. Carbanilide VI and VII
did not alter the signal significantly. Taken
together, the results observed in the two cell
lines strongly support the ability of a number
of the carbanilide compounds to interact with
the AR or AR-signal transduction pathway,
leading to enhancement of AR-dependent
gene expression.
The above results indicate the ability of
TCC and other compounds to enhance hor-
mone-, ER-, and AR-dependent reporter gene
expression. Given the environmental and
exposure relevance of TCC, we examined the
concentration-dependent nature of the TCC-
dependent enhancing effect in both cell bio-
assay systems. We examined the effect of
increased concentrations of TCC in the cell
incubation medium (up to a maximum of
1 μM; we observed toxicity at higher concen-
trations) on ER- and AR-dependent gene
expression levels using maximally inducing
concentrations of E2 or testosterone, respec-
tively. These analyses reveal a TCC concentra-
tion-dependent enhancement of E2- and
testosterone-dependent reporter gene expres-
sion (Figure 5). In contrast, coincubation with
TCS (VIII) resulted in a TCS concentration-
dependent decrease of E2-dependent reporter
gene expression, with 50% inhibition
observed at a concentration of 1 μM TCS
(Figure 6). TCS did not exhibit estrogenic
activity at any concentration shown in the
absence of E2.
RyR-responsive bioassay. TCS significantly
increased the amount of [3H]Ry binding to
microsomes enriched in RyR1 from skeletal
muscle (Figure 7). We measured net changes in
intracellular Ca2+ concentration in myotubes
with the fluorometric dye fura-2. The initial
rate of Ca2+ increase in the cytoplasm in resting
myotubes depends on the concentration of
TCS (0.5–10 μM) perfused in the medium
(Figure 8A). As shown in Figure 8B, TCS
increased cytosolic Ca2+ concentrations even in
the presence of a buffer containing nominally
free extracellular Ca2+ (~ 7 μM), indicating that
TCS can mobilize Ca2+ to the cytoplasm from
endoplasmic reticulum/sarcoplasmic reticulum
and/or mitochondrial intracellular stores
(Figure 8B). The carbanilide compounds,
including TCC, showed no significant pertur-
bation of resting Ca2+ concentration when
perfused at ≤ 10 μM (data not shown). TCS
has a noncoplanar configuration and substitu-
tions at the ortho position similar to PCB-95,
one of the most active congeners toward RyR1
(Pessah et al. 2006; Wong and Pessah 1996)
Bioactivities of triclocarban, its analogs, and triclosan
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Figure 3. Effects of carbanilide compounds at 1 (10–6 M) and 10 µM (10–5 M) on ER- and AR-mediated activ-
ity in the absence (A and C) and presence (B and D) of E2 (1 nM; A and B) or testosterone (T; 10 µM; C and
D) in ER-responsive (BG1-ERE cells) or AR-responsive (T47D-ARE cells) bioassay.
*Significantly greater than the solvent control (A and C) or E2 or T positive controls (B and D) at p < 0.05 for agonist/ampli-
fication evaluation. #Cell toxicity at 10-µM concentration. 
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Figure 4. Effects of 1-µM carbanilide compounds on the AR-mediated activity in the absence (A) and the
presence (B) of testosterone (T; 0.1 nM) in the HEK-2933Y AR-responsive cell system. The activity by car-
banilide compounds I–V was reported by Chen et al. (2008). 
*Significantly greater than the solvent control (A) or T positive control (B) at p < 0.05 for agonist/amplification evaluation.
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(Figure 9). However, TCS is significantly less
hydrophobic than PCB-95 (log p = 4.76 vs.
6.55, respectively). Also, because of the ether
linkage, TCS is significantly longer and more
flexible than is PCB-95. TCS activity at RyR1
may therefore reflect its ability to assume a
conformation like those of noncoplanar PCBs.
Results from molecular modeling indicate
that TCS has around 67° and 100° dihedral
angles formed by the two phenyl rings, similar
to the configuration of PCB-95, which has
around 78° and 113° dihedral angles, support-
ing the importance of noncoplanarity for RyR
activity.
Discussion
We have examined the biological activity of
the antimicrobial TCC, its carbanilide
analogs, and TCS in in vitro and cell-based
AhR, ER, AR, and RyR bioassays. Although
TCC and other carbanilide compounds exhib-
ited no significant or weak agonist activity in
the ER and AR cell bioassays, most of the
compounds enhanced the ability of the steroid
hormones E2 and testosterone to induce ER-
and AR-dependent reporter gene expression in
recombinant cell bioassays. In contrast,
although TCS and most carbanilides, with the
exception of compound VI, exhibited weak
agonistic and/or antagonistic activity in the
AhR-responsive cell bioassay (Table 1), none
of these compounds significantly enhanced the
ability of TCDD to induce reporter gene
expression. These results indicate that these
chemicals exhibit distinct mechanisms of
action on these distinctly different ligand-
dependent nuclear receptor signaling pathways.
The signal enhancement activities by the
carbanilide compounds were not involved in
cell proliferation. At concentrations < 1 μM,
TCC, its analogs, and TCS showed no signifi-
cant effect on ATP levels for cell proliferation/
cytotoxicity by the ViaLight kit in HEK-293
cells relative to the solvent control (data not
shown). ViaLight cell proliferation and cyto-
toxicity assay was performed according to
manufacturer instructions (Cambrex, Inc.,
East Rutherford, NJ). Similarly, < 1 μM,
TCC showed no significant effect on
methylthiazol tetrazolium activity in the
HEK 2933Y-ARE cell proliferation assay
(Chen et al. 2008). Some compounds exhib-
ited cytotoxic effects at concentrations
> 10 μM in HEK-2933Y-ARE, T47D-ARE,
and BG1-ERE cell lines.
Because relatively small quantities of
impurities may obscure the results for TCC,
we further purified commercial TCC pur-
chased at a purity of 99.8% by recrystalliza-
tion, and we estimated higher purity
(~ 100%) of TCC at 270 nm by HPLC. We
evaluated the recrystallized TCC for the
enhancement effect in the ER- and AR-medi-
ated bioassays. The results were not signifi-
cantly different from those in the bioassays
using the commercial TCC (data not shown),
so we conclude that the steroid-enhancing
activity is mediated by the chemicals them-
selves and not by a contaminant(s).
Although the trend of the enhancing
activity produced by several carbanilides in
the presence of testosterone in androgen-
responsive recombinant T47D breast cancer
cells and HEK-2933Y cells is similar, we
demonstrated the testosterone concentrations
at which we observed enhanced induction to
be distinctly different. The different outcomes
may result from a cell-type–specific biological
response for the testosterone-induced AR-
dependent luciferase reporter gene expression
and from differences between the endogenous
AR in T47D cancer cells and the exogenous
transformed AR in HEK-2933Y cells, as well
as differences in the specific interlaboratory
protocols.
Enhanced gene expression by carbanilide
compounds in the presence of endogenous
steroids in the AR- and ER-mediated reporter
gene bioassays (present study) and the
increased expression of AR protein by TCC
and testosterone in MDA-kb2 human breast
cancer cells (Chen et al. 2008) suggest that the
carbanilides may sensitize the complex of
Ahn et al.
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Figure 6. Activity of TCS in the ER-mediated bioassay. 
*Significantly different from the control. 
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receptor-associating proteins similar to cofac-
tors or coactivators common in cells contain-
ing ER and AR (Chang and McDonnell
2005; McDonnell and Norris 2002). Such an
interaction would allow the DNA-bound
receptor to enhance the overall rate of tran-
scription of the target gene as evidenced by the
similar response in both ER- and AR-respon-
sive systems. An in vitro AR binding assay
using the rat AR ligand-binding domain and
competitive fluorescence polarization measure-
ment showed that TCC did not directly com-
pete with testosterone for AR binding (Chen
et al. 2008). However, further investigation is
needed to determine whether TCC increases
the activity of sex steroid hormones by bind-
ing to the receptors or to receptor coactivators.
Among the carbanilide compounds that
showed gene induction enhancement, II, III
(TCC), and IV are found in effluent from
wastewater treatment plants; they likely result
from use of personal care products or from
synthesis and production of TCC or the
phenylurea herbicide diuron (Sapkota et al.
2007). Carbanilide (compound I) without
elemental chlorine can be obtained as a by-
product in the synthesis of the phenylurea her-
bicide siduron when it is prepared from phenyl
isocyanate. 1,3-Dicyclohexylurea (VI) has satu-
rated cyclohexyl rings rather than phenyl rings
of compound I, and compound VI exhibited
both strong agonistic and amplification activi-
ties, particularly in the ER-mediated bioassay.
It is obtained in an equal molar ratio as an
industrial waste by-product, along with the
desired product, by dicyclohexylcarbodiimide-
mediated coupling reactions for common
peptide synthesis. 
Hard bar soaps containing TCC, added at
concentrations from about 0.6% up to 1.5%,
are normally used by consumers for personal
care purposes. The physicochemical properties
of TCC suggest that it will penetrate the skin
poorly, and this prediction is supported by lim-
ited experimental data (Halden and Paull
2005). However, soaps provide good emol-
lients to accelerate dermal penetration of TCC.
The increasing use of TCC in personal care
products results in increased human exposure.
Also of concern are TCC’s recalcitrance to
environmental degradation and its tendency to
bind tightly to organic materials such as bio-
solids from sewage sludge that are reapplied to
land for agriculture and other uses. Taken
together, these data suggest caution in its
continued use.
Possibly of broader significance is the illus-
tration of a new mechanism of action for TCC
as an EDC. The enhancement characteristics
of TCC and its carbanilide analogs on endoge-
nous/exogenous androgens and estrogens, in
contrast to antagonist activity of TCS, may
have an effect on possible normal physiology
and/or reproduction in both males and
females. Consider that synthetic and natural
hormones used as growth promoters in cattle,
which are eaten by women during pregnancy,
have been shown to interfere with reproduc-
tion and may be involved in reduced sperm
quality in their sons (Swan et al. 2007).
Exposure to TCC together with the steroid
hormones in women may result in similar poor
sperm quality because testicular development
may be altered in utero. An animal study has
indicated that chronic oral administration of
high doses of TCC to male rats resulted in tes-
ticular degeneration (Scientific Committee on
Consumer Products 2005). The Hershberger
assay for in vivo screening to evaluate the syn-
ergistic effect of testosterone by TCC demon-
strated that the treatment of 0.25% (wt/wt)
TCC mixed in rat chow in the presence of
testosterone propionate (0.2 mg/kg by sub-
cutaneous injection) significantly increased the
weight of accessory sex organs and tissues of
reproductive tracts of castrated male Sprague
Dawley rats, compared with rats given testos-
terone treatment alone (Chen et al. 2008).
Human exposure to TCC contained in com-
mercial personal care soaps that are frequently
used may enhance the activity of endogenous
sex steroid hormones, suggesting that TCC as
an EDC may affect male reproductive sys-
tems. In females, because the breast can be
exposed to antimicrobial TCC-containing
products such as soap and deodorants applied
to the underarm and breast area, TCC ampli-
fication of E2-induced ER activity may harm
patients with ER-positive breast cancer. These
studies suggest the importance of evaluating
the relative benefits and risks of TCC found in
personal care products.
The content of TCS ranges from 0.1% to
1% in personal care products, and may reach
1% in medicated materials such as gloves/
scrubs used in hospitals where strong germici-
dal activity is needed. Because of its popular
use, environmental residues have been detected
at microgram per liter levels, suggesting exten-
sive contamination of aquatic ecosystems and
bioaccumulation in biota. Contrary to studies
showing that TCS provided little or no estro-
genic activity in the estrogen-dependent 
systems (Foran et al. 2000; Houtman et al.
2004; Ishibashi et al. 2004), we found that
TCS exhibited antagonist activity in the ER-
mediated bioassay (Figure 6), as it did in the
AR-mediated assay (Chen et al. 2007; Tamura
et al. 2006). Its phenolic structural relationship
to nonsteroidal estrogens such as diethylstilbe-
strol and bisphenol A also raises concerns.
Furthermore, TCS is structurally similar to
noncoplanar ortho-substituted PCBs (Figure 9)
and sensitizes the channel of an RyR found in
various forms of muscle and other excitable
animal tissue. Our results (Figures 7 and 8) are
the first to identify RyRs as sensitive targets of
TCS and provide a potent tool for understand-
ing mechanisms regulating the structure and
function of Ca2+ release complexes. These new
results provide additional concern for TCS as
an EDC and concern that it has potential
neurotoxicity, which taken together with a
finding that TCS disrupts thyroid action for
normal growth and development of humans
and wildlife (Veldhoen et al. 2006), suggests
reevaluation of its use in consumer products.
In conclusion, we used a battery of mecha-
nism-based screening bioassays developed by
the University of California Superfund Basic
Research Program for detection of toxicants
and assessment of exposure to toxic substances
with a selected series of carbanilides and TCS.
As summarized in Table 2, we found that a
group of carbanilides, including the anti-
microbial TCC, enhances effects of steroid
hormones in ER- and AR-dependent gene
expression bioassays, although the compounds
have minor endocrine activity on their own,
suggesting a new class of EDC. In general, the
carbanilide compounds except for dicyclohexyl-
urea (VI), which acted as an agonist, provided
antagonistic activity in the AhR-responsive cell
Bioactivities of triclocarban, its analogs, and triclosan
Environmental Health Perspectives • VOLUME 116 | NUMBER 9 | September 2008 1209
Table 2. The biological activity of TCC, its analogs, and TCS in the receptor bioassay screens.
AhR (H4L1.1c4-DRE cells) ER (BG1-ERE cells) AR (T47D-ARE or HEK2933Y-ARE cells)
Compound Compound alone With 1 nM TCDD Compound alone With 1 nM E2 Compound alone With 0.1 nM or 10 µM T RyR ([3H]Ry binding)
I – + (ant) + (ag) + (amp) + (aga) + (ampa,b) –
II – + (ant) + (ag) + (amp) + (aga) + (ampa,b) –
III (TCC) – + (ant) + (ag) + (amp) – + (ampa,b) –
IV – + (ant) + (ag) – – + (ampa,b) –
V – + (ant) + (ag) + (amp) – (aga) + (ampb) –
VI + (ag) – + (ag) + (amp) – + (ampa) –
VII + (ag) + (ant) + (ag) + (amp) – – –
VIII (TCS) + (ag) + (ant) – + (ant) – + (antb) + (sensitive)
Abbreviations: –, no effect; +, positive effect; ag, agonistic; amp, amplification; ant, antagonistic. 
a Data from T47D-ARE bioassays. b Data from HEK 2933Y-ARE bioassay. 
bioassay. Similar to noncoplanar ortho-substi-
tuted PCBs, the noncoplanar antimicrobial
compound TCS exhibited weak AhR activity
but was a potent antagonist in both ER-medi-
ated and AR-mediated bioassays and a potent
channel sensitizer in an RyR-mediated bioassay
and dysregulator of cell Ca2+ homeostasis.
These observations have potentially significant
implications regarding human and animal
health because exposure may be directly
through dermal contact or indirectly through
the food chain. These screening studies revealed
that further investigations into the biological
and toxicologic effects of TCC, its carbanilide
analogs, and TCS are urgently needed.
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CORRECTION
In Figure 2 of the original manuscript pub-
lished online, the concentration of TCC
was incorrect; it has been corrected here. 
